Skip to main content

Table 1 Comparison of baseline demographic and clinical parameters between the two groups

From: The use of optical coherence tomography angiography in comparing choriocapillaris recovery between two treatment strategies for multifocal choroiditis: a pilot clinical trial

 

Group 1 (n = 11 eyes)

Group 2 (n = 14 eyes)

P value

Age (years ± SD)

30.4 ± 8.3

32.4 ± 11.5

0.62

Gender (n)

  

0.20

Male

6

11

Female

5

3

Diagnosis (n)

  

0.82

TB SLC

6

7

MFC

5

7

Laterality (n)

  

0.89

Right eye

6

8

Left eye

5

6

Treatments (n)

   

Intravitreal DEX

12

Intravitreal MTX

2

ATT

6

7

Oral corticosteroids

11

14

Initial BCVA (LogMAR units)

0.41 ± 0.25

0.38 ± 0.23

0.85

Final BCVA (LogMAR units)

0.32 ± 0.23

0.15 ± 0.11

0.025

(p value)*

(0.01)

(< 0.001)

Initial IOP

(mm Hg)

13.6 ± 1.7

13.7 ± 2.2

0.92

Final IOP (mm Hg)

14.1 ± 2.1

14.4 ± 3.8

0.82

(p value)*

(0.51)

(0.58)

  1. *p value has been calculated compared to baseline
  2. ATT Anti-tubercular therapy, BCVA Best-corrected visual acuity, DEX Dexamethasone implant, IOP Intraocular pressure, MFC Multifocal choroiditis, MTX Methotrexate, TB SLC Tubercular serpiginous-like choroiditis